SCOPUS 정보 검색 플랫폼

Lancet

Volumn 357, Issue 9273, 2001, Pages 1991-1992

Leukotriene antagonists and symptom control in chronic persistent asthma

(2) Green, Ruth H a Pavord, Ian D a

a GLENFIELD HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ARACHIDONATE 5 LIPOXYGENASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE; ZAFIRLUKAST;

AIRWAY PRESSURE; ASTHMA; BRONCHOSPASM; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EXPIRED AIR; FORCED EXPIRATORY VOLUME; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFLAMMATION; LUNG FUNCTION; NOTE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPUTUM EXAMINATION; SYMPTOM;

EID: 0035938932 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(00)05132-1 Document Type: Note

Times cited : (17)

References (19)

1
- 0026550488
- Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist
- (1992) Am Rev Respir Dis , vol.145 , pp. 746-749
- Finnerty, J.P.¹ Wood-Baker, R.² Thomson, H.³ Holgate, S.T.⁴

2
- 0025596976
- Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist
- (1990) N Engl J Med , vol.323 , pp. 1736-1739
- Manning, P.J.¹ Watson, R.M.² Margolskee, D.J.³ Williams, V.C.⁴ Schwartz, J.I.⁵ O'Byrne, P.M.⁶

3
- 0026066945
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
- (1991) Lancet , vol.337 , pp. 690-694
- Taylor, I.K.¹ O'Shaughnessy, K.M.² Fuller, R.W.³ Dollery, C.T.⁴

4
- 0032950143
- The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma
- (1999) Clin Exp Allergy , vol.29 , pp. 42-51
- Diamant, Z.¹ Grootendorst, D.C.² Veselic-Charvat, M.³

5
- 0028103864
- Effects of 6 weeks of therapy with oral doses of ICI 204219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma
- ACCOLATE Asthma Trialists Group
- (1994) Am J Respir Crit Care Med , vol.150 , pp. 618-623
- Spector, S.L.¹ Smith, L.J.² Glass, M.³

6
- 0031024694
- Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
- (1997) Thorax , vol.52 , pp. 45-48
- Reiss, T.F.¹ Sorkness, C.A.² Stricker, W.³

7
- 18744421762
- Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction
- (1998) N Engl J Med , vol.339 , pp. 147-152
- Leff, J.A.¹ Busse, W.W.² Pearlman, D.³

8
- 0032866048
- Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
- (1999) Eur Respir J , vol.14 , pp. 12-18
- Pizzichini, E.¹ Leff, J.A.² Reiss, T.F.³

9
- 0033456233
- Induced sputum eicosanoid concentrations in asthma
- (1999) Am J Respir Crit Care Med , vol.160 , pp. 1905-1909
- Pavord, I.D.¹ Ward, R.² Woltmann, G.³ Wardlaw, A.J.⁴ Sheller, J.R.⁵ Dworski, R.⁶

10
- 0033837039
- Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids
- (2000) Am J Respir Crit Care Med , vol.162 , pp. 578-585
- Christian, V.J.¹ Prasse, A.² Naya, I.³ Summerton, L.⁴ Harris, A.⁵

11
- 0033542645
- Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
- (1999) BMJ , vol.319 , pp. 87-90
- Lofdahl, C.G.¹ Reiss, T.F.² Leff, J.A.³

12
- 0033059209
- Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
- (1999) Nat Genet , vol.22 , pp. 168-170
- Drazen, J.M.¹ Yandava, C.N.² Dube, L.³

13
- 0033803781
- Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
- (2000) Thorax , vol.55 , Issue.SUPPL. 2
- Sampson, A.P.¹ Siddiqui, S.² Buchanan, D.³

14
- 0034643636
- Regular inhaled salbutamol and asthma control: The TRUST randomised trial
- Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework
- (2000) Lancet , vol.355 , pp. 1675-1679
- Dennis, S.M.¹ Sharp, S.J.² Vickers, M.R.³

15
- 0029963172
- Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms
- (1996) Chest , vol.109 , pp. 697-701
- Joyce, D.P.¹ Chapman, K.R.² Kesten, S.³

16
- 85007263204
- Diagnosing mild asthma. Which test is best?
- abstr
- (1999) Am J Respir Crit Care Med , vol.159
- Hunter, C.J.¹ Brightling, C.E.² Woltmann, G.³ Wardlaw, A.J.⁴ Pavord, I.D.⁵

17
- 0027323401
- Validity of peak expiratory flow rate variability for the diagnosis of asthma
- (1993) Clin Sci (Colch) , vol.85 , pp. 367-371
- Jamison, J.P.¹ McKinley, R.K.²

18
- 0028264310
- Added salmeterol versus higher-dose corcitocsteroid
- Allen&Hanburys Ltd UK Study Group
- (1994) Lancet , vol.344 , pp. 219-224
- Greening, A.P.¹ Ind, P.W.² Northfield, M.³ Shaow, G.⁴

19
- 1842370350
- Effect of inhaled formoterol and budesonide on exacerbations of asthma
- Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
- (1997) N Engl J Med , vol.337 , pp. 1405-1411
- Pauwels, R.A.¹ Lofdahl, C.G.² Postma, D.S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.